Get the Stockscreener App
3.11
2.20%
-0.07
After Hours:
3.12
0.01
+0.32%
Artiva Biotherapeutics Inc stock is traded at $3.11, with a volume of 38,071.
It is down -2.20% in the last 24 hours and up +3.32% over the past month.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
See More
Previous Close:
$3.18
Open:
$3.14
24h Volume:
38,071
Relative Volume:
0.20
Market Cap:
$75.96M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.58%
1M Performance:
+3.32%
6M Performance:
-29.16%
1Y Performance:
-72.67%
1-Day Range:
$3.0744
$3.21
1-Week Range:
$3.00
$3.3014
52-Week Range:
$1.47
$17.31
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
Name
Artiva Biotherapeutics Inc
Sector
Industry
Phone
(858) 267-4467
Address
5505 MOREHOUSE DRIVE, SAN DIEGO
Compare ARTV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
3.11 | 75.28M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-11-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| Aug-13-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-13-24 | Initiated | Jefferies | Buy |
| Aug-13-24 | Initiated | Needham | Buy |
| Aug-13-24 | Initiated | TD Cowen | Buy |
| Aug-13-24 | Initiated | Wedbush | Outperform |
View All
Artiva Biotherapeutics Inc Stock (ARTV) Latest News
Will Artiva Biotherapeutics Inc. benefit from rate cutsJuly 2025 Institutional & Reliable Price Action Trade Plans - khodrobank.com
How to build a custom watchlist for Artiva Biotherapeutics Inc.Trade Analysis Report & Momentum Based Trading Ideas - Newser
How moving averages guide Artiva Biotherapeutics Inc. tradingTrade Volume Report & Real-Time Sentiment Analysis - Newser
Can Artiva Biotherapeutics Inc. stock outperform in a bear market2025 Earnings Surprises & Technical Analysis for Trade Confirmation - khodrobank.com
Candlestick signals on Artiva Biotherapeutics Inc. stock todayPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Real time scanner hits for Artiva Biotherapeutics Inc. explainedQuarterly Portfolio Summary & Proven Capital Preservation Tips - Newser
Backtesting results for Artiva Biotherapeutics Inc. trading strategies2025 Market Overview & Smart Allocation Stock Reports - Newser
Can Artiva Biotherapeutics Inc. hit a new high this month2025 Biggest Moves & Trade Opportunity Analysis Reports - Newser
Analyzing drawdowns of Artiva Biotherapeutics Inc. with statistical toolsJuly 2025 Levels & Low Risk Entry Point Guides - Newser
Will Artiva Biotherapeutics Inc. see short term momentum2025 Top Gainers & High Conviction Buy Zone Alerts - Newser
Applying Wyckoff theory to Artiva Biotherapeutics Inc. stockQuarterly Market Summary & Expert Approved Momentum Ideas - Newser
Artiva Biotherapeutics Inc. stock trendline breakdownWeekly Stock Recap & Daily Oversold Bounce Ideas - Newser
Risk vs reward if holding onto Artiva Biotherapeutics Inc.Market Sentiment Report & Reliable Price Action Trade Plans - Newser
Using Python tools to backtest Artiva Biotherapeutics Inc. strategies2025 Risk Factors & AI Powered Market Entry Strategies - Newser
Can Artiva Biotherapeutics Inc. deliver consistent dividendsWeekly Trend Report & Community Consensus Trade Signals - khodrobank.com
Does Artiva Biotherapeutics Inc. stock have upside surprise potential2025 Macro Impact & Safe Swing Trade Setup Alerts - khodrobank.com
Leading vs lagging indicators on Artiva Biotherapeutics Inc. performance2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser
Using data filters to optimize entry into Artiva Biotherapeutics Inc.Trade Exit Report & Community Consensus Picks - Newser
Historical volatility pattern of Artiva Biotherapeutics Inc. visualizedJuly 2025 Catalysts & Growth Focused Entry Point Reports - Newser
Is Artiva Biotherapeutics Inc. forming a bottoming base2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
What’s the beta of Artiva Biotherapeutics Inc. stockJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Risk Recap: Is Artiva Biotherapeutics Inc. a top pick in the sectorWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - khodrobank.com
Will Artiva Biotherapeutics Inc. outperform its industry peersTrade Volume Report & Pattern Based Trade Signal System - khodrobank.com
Predicting Artiva Biotherapeutics Inc. trend using moving averages2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Can Artiva Biotherapeutics Inc. sustain earnings growthJuly 2025 Patterns & Reliable Intraday Trade Alerts - khodrobank.com
Is a relief rally coming for Artiva Biotherapeutics Inc. holdersJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - Newser
Sector ETF performance correlation with Artiva Biotherapeutics IncMarket Growth Summary & AI Driven Stock Movement Reports - Newser
Sector ETF performance correlation with Artiva Biotherapeutics Inc.Weekly Profit Recap & Fast Entry Momentum Trade Alerts - Newser
Will Artiva Biotherapeutics Inc. benefit from macro trends2025 Top Gainers & Safe Entry Momentum Tips - Newser
Artiva Biotherapeutics Inc. recovery potential after sell offJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
How to use Fibonacci retracement on Artiva Biotherapeutics Inc.2025 Stock Rankings & Growth Oriented Trading Recommendations - Newser
How institutional ownership impacts Artiva Biotherapeutics Inc. stockJuly 2025 Macro Moves & Entry Point Confirmation Signals - Newser
Detecting support and resistance levels for Artiva Biotherapeutics Inc.Portfolio Gains Report & Safe Swing Trade Setups - Newser
Artiva Biotherapeutics Inc Stock (ARTV) Financials Data
There is no financial data for Artiva Biotherapeutics Inc (ARTV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):